Inhaled corticosteroids in COPD.

Inhaled corticosteroids in COPD.

書誌詳細
主要な著者:	Brightling, C, Pavord, I
フォーマット:	Journal article
言語:	English
出版事項:	1999

類似資料

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
著者:: Saha, S, 等
出版事項: (2006)

Inhaled corticosteroids in COPD (multiple letters) [1]
著者:: Hart, S, 等
出版事項: (1999)

Inhaled glucocorticoids and COPD exacerbations.
著者:: Brightling, C, 等
出版事項: (2015)

Minimising inhaled corticosteroids for COPD
著者:: Benji Heran, 等
出版事項: (2024-12-01)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
著者:: Siddiqui, S, 等
出版事項: (2018)

The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
著者:: Russell, R, 等
出版事項: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
著者:: Siddiqui SH, 等
出版事項: (2018-11-01)

Inhaled Corticosteroids and the Lung Microbiome in COPD
著者:: Holly R. Keir, 等
出版事項: (2021-09-01)

How inhaled corticosteroids target inflammation in COPD
著者:: Simon Lea, 等
出版事項: (2023-10-01)

Rational use of inhaled corticosteroids for the treatment of COPD
著者:: Jennifer K. Quint, 等
出版事項: (2023-07-01)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
著者:: Berry, M, 等
出版事項: (2007)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
著者:: Green, R, 等
出版事項: (2006)

Reply to: inhaled corticosteroids and adult asthma
著者:: Beasley, R, 等
出版事項: (2019)

Counterpoint: Should an attempt be made to withdraw inhaled corticosteroids in all patients with stable GOLD 3 (30% ≤ FEV1 < 50% predicted) COPD? No.
著者:: Pavord, I
出版事項: (2018)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
著者:: Green, R, 等
出版事項: (2002)

The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
著者:: Ricardo G. Figueiredo, 等
出版事項: (2022-08-01)

The dose of inhaled corticosteroids in patients with COPD: when less is better
著者:: Izquierdo JL, 等
出版事項: (2018-10-01)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
著者:: Koehorst-ter Huurne K, 等
出版事項: (2016-07-01)

COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids
著者:: Ozcakir S, 等
出版事項: (2020-10-01)

Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
著者:: Liu SF, 等
出版事項: (2016-07-01)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
著者:: Cheng S, 等
出版事項: (2017-07-01)

Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short
著者:: Tantucci C, 等
出版事項: (2020-04-01)

Prevalence and clinical features of asthma-COPD overlap in patients with COPD not using inhaled corticosteroids
著者:: Kuniaki Hirai, 等
出版事項: (2021-01-01)

Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
著者:: Soltani A, 等
出版事項: (2016-09-01)

Biomarkers predicting response to corticosteroid therapy in asthma.
著者:: Brightling, C, 等
出版事項: (2005)

Asthma progression and mortality: The role of inhaled corticosteroids
著者:: O'Byrne, P, 等
出版事項: (2019)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
著者:: Antonio Oliver, 等
出版事項: (2021-01-01)

Inhaled Corticosteroids in COPD: Determinants of Use and Trends in Patient Persistance with Treatment
著者:: Lucie Blais, 等
出版事項: (2004-01-01)

Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
著者:: Miravitlles M, 等
出版事項: (2022-01-01)

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
著者:: Cataldo D, 等
出版事項: (2018-07-01)

Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication
著者:: Koehorst-ter Huurne K, 等
出版事項: (2018-09-01)

Non-eosinophilic corticosteroid unresponsive asthma.
著者:: Pavord, I, 等
出版事項: (1999)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
著者:: Janson C, 等
出版事項: (2017-10-01)

Prednisolone response in patients with COPD.
著者:: Pavord, I, 等
出版事項: (2004)

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
著者:: Bafadhel, M, 等
出版事項: (2009)

Inhaled Corticosteroids
著者:: Peter J. Barnes
出版事項: (2010-03-01)

Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
著者:: Bloom CI, 等
出版事項: (2020-04-01)

Rational use of inhaled corticosteroids for the treatment of COPD: a plain language summary
著者:: Amnon Ariel, 等
出版事項: (2023-11-01)

Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
著者:: Mario Cazzola, 等
出版事項: (2023-07-01)

A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
著者:: Smit Patel, 等
出版事項: (2022-07-01)